APA (7th ed.) Citation

Kubesch, A., Lande, R., Leutgöb, A., Farrag, K., Dahmer, I., Stratmann-Vollrath, K., . . . Blumenstein, I. (2025). Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A tertiary referral center study on patients with therapy-refractory ulcerative colitis. PLoS ONE, 20(10), 1. https://doi.org/10.1371/journal.pone.0334897

Chicago Style (17th ed.) Citation

Kubesch, Alica, et al. "Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A Tertiary Referral Center Study on Patients with Therapy-refractory Ulcerative Colitis." PLoS ONE 20, no. 10 (2025): 1. https://doi.org/10.1371/journal.pone.0334897.

MLA (9th ed.) Citation

Kubesch, Alica, et al. "Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A Tertiary Referral Center Study on Patients with Therapy-refractory Ulcerative Colitis." PLoS ONE, vol. 20, no. 10, 2025, p. 1, https://doi.org/10.1371/journal.pone.0334897.